Fund for Global Human Rights UK is a privately-limited guaranteed nominal company established in 2013 under the SIC Codes - 96090: Other service activities n.e.c. It operates as an investment fund focused on supporting global human rights initiatives through financial support. The organization’s primary mission centers around empowering individuals and communities to advocate for social justice, environmental protection, and ethical development worldwide. The company currently manages a $15 million Series B funding round secured from Medical Technology Venture Partners and new investors. This capital will be strategically allocated towards expanding the Thoraguard® System – a groundbreaking digital surgical technology platform designed to improve patient outcomes. The expansion includes significant investments in research & development, manufacturing capabilities, and market penetration across key international territories. Centese, Inc., a recognized leader in digital surgery technology, has appointed Timothy Still as a director on their Board of Directors. The company’s activities span diverse sectors including healthcare technology, medical devices, and software solutions. The fund's focus remains firmly dedicated to advancing human rights through impactful investments.

Fund for Global Human Rights UK is a privately-limited guaranteed nominal company established in 2013 under the SIC Codes - 96090: Other service activities n.e.c. It operates as an investment fund focused on supporting global human rights initiatives through financial support. The organization’s primary mission centers around empowering individuals and communities to advocate for social justice, environmental protection, and ethical development worldwide. The company currently manages a $15 million Series B funding round secured from Medical Technology Venture Partners and new investors. This capital will be strategically allocated towards expanding the Thoraguard® System – a groundbreaking digital surgical technology platform designed to improve patient outcomes. The expansion includes significant investments in research & development, manufacturing capabilities, and market penetration across key international territories. Centese, Inc., a recognized leader in digital surgery technology, has appointed Timothy Still as a director on their Board of Directors. The company’s activities span diverse sectors including healthcare technology, medical devices, and software solutions. The fund's focus remains firmly dedicated to advancing human rights through impactful investments.